NSE · NEULANDLAB.NS
Neuland Laboratories Limited
₹19,630.00+₹350.00 (+1.82%)
Neuland Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 18.97% below the high.
Loading market information…
NSE · RPGLIFE.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:21 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
RPG Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 15.18% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
RPG Life Sciences Limited’s forward annual dividend is ₹16.00 per share, paid annual. The forward yield is 0.6% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow RPG Life Sciences Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
RPG Life Sciences Limited operates as a fully integrated pharmaceutical enterprise, engaged in the development, production, and commercialization of branded drug formulations, generic medications, and synthetic active pharmaceutical ingredients (APIs) for both the Indian and global markets. The company provides synthetic APIs for diverse medical applications, including immunosuppression, psychiatric conditions, cardiac health (anti-anginals), parasitic infections (anthelmentics), seizure management (anticonvulsants), and muscle spasm relief (antispasmodics). While its generics portfolio primarily centers on immunosuppressant treatments, its finished dosage formulations address a wide spectrum of therapeutic areas, such as nephrology, rheumatology, oncology, gastroenterology, cardiovascular health, diabetology, orthopedics, neuropsychiatry, and respiratory conditions, among many others. Established in 1968 with its headquarters in Mumbai, India, the company adopted its current name in February 2008, having previously been known as RPG Pharmaceuticals Limited. RPG Life Sciences Limited functions as a subsidiary of Nucleus Life Trust.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| ₹1.73B+107.97% vs estimate |
| Q2 2025 | Nov 7, 2024 | ₹2.54-34.37% vs estimate | ₹1.72B+107.37% vs estimate |
|---|
| Q1 2025 | Jul 19, 2024 | ₹16.18 | ₹1.65B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹19,630.00+₹350.00 (+1.82%)
Neuland Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 18.97% below the high.
₹846.30+₹8.95 (+1.07%)
Granules India Limited’s quoted price sits in the upper half of its reported 52-week range, 8.49% below the high.
₹1,433.10+₹35.70 (+2.55%)
Alivus Life Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 4.36% below the high.
₹452.15-₹29.20 (-6.07%)
Cohance Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 43.39% below the high.
₹510.00+₹24.20 (+4.98%)
SMS Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 3.15% below the high.
₹854.60-₹38.80 (-4.34%)
Orchid Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 25.26% below the high.
₹442.35-₹6.65 (-1.48%)
Aarti Drugs Limited’s quoted price sits in the upper half of its reported 52-week range, 17.15% below the high.
₹637.00-₹18.25 (-2.79%)
Solara Active Pharma Sciences Limited’s quoted price sits in the upper half of its reported 52-week range, 17.7% below the high.
